Anesth Analg 2005;100:929-936
© 2005 International Anesthesia Research Society
doi: 10.1213/01.ANE.0000147707.49192.88
CARDIOVASCULAR ANESTHESIA
Propofol Attenuates Lung Endothelial Injury Induced by Ischemia-Reperfusion and Oxidative Stress
Irina V. Balyasnikova, PhD,
David J. Visintine, BA,
Helena B. Gunnerson, MD,
Chanannait Paisansathan, MD,
Verna L. Baughman, MD,
Richard D. Minshall, PhD, and
Sergei M. Danilov, MD, PhD
Departments of Anesthesiology and Pharmacology, University of Illinois at Chicago, Chicago, Illinois
Address correspondence and reprint requests to Sergei M. Danilov, MD, PhD, Anesthesiology Research Center, University of Illinois at Chicago, 1819 W. Polk St. (M/C 519), Chicago, IL 60612. Address e-mail to danilov{at}uic.edu.
Lung dysfunction after cardiopulmonary bypass and lung transplantation results from oxidant-mediated cellular damage. Previously, we observed the shedding of angiotensin-converting enzyme (ACE) from the endothelial cell surface to be a more sensitive and earlier marker of oxidative lung endothelial injury than lung wet-to-dry weight ratio. The aim of this study was to evaluate the potential of the anesthetic propofol, which has antioxidant properties, to prevent oxidative lung injury by measuring ACE shedding. ACE release from isolated perfused rat lungs increased significantly after ischemia-reperfusion (I/R). Propofol significantly decreased I/R-induced ACE release by 23.4% (P < 0.05). Perfusion with 0.75 mM H2O2 also caused ACE release from the lung microvasculature, which was similarly attenuated by propofol. The protective effect of propofol on H2O2-induced ACE shedding was confirmed in vitro using Chinese Hamster Ovary cells overexpressing human ACE. Thus, propofol can attenuate oxidative injury of the pulmonary endothelium as detected by ACE shedding in I/R and H2O2 models of acute lung injury.
This article has been cited by other articles:

|
 |

|
 |
 
A. R. Assad, J. M. A. Delou, L. M. Fonseca, N. R. Villela, J. H. M. Nascimento, N. Vercosa, A. G. Lopes, and M. A.M. Capella
The Role of KATP Channels on Propofol Preconditioning in a Cellular Model of Renal Ischemia-Reperfusion
Anesth. Analg.,
November 1, 2009;
109(5):
1486 - 1492.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Soler, M. Ye, J. Wysocki, J. William, J. Lloveras, and D. Batlle
Localization of ACE2 in the renal vasculature: amplification by angiotensin II type 1 receptor blockade using telmisartan
Am J Physiol Renal Physiol,
February 1, 2009;
296(2):
F398 - F405.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X.-J. Zou, L. Yang, and S.-L. Yao
Propofol Depresses Angiotensin II-Induced Cardiomyocyte Hypertrophy In Vitro
Experimental Biology and Medicine,
February 1, 2008;
233(2):
200 - 208.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. G. Votta-Velis, R. D. Minshall, D. J. Visintine, M. Castellon, and I. V. Balyasnikova
Propofol Attenuates Endotoxin-Induced Endothelial Cell Injury, Angiotensin-Converting Enzyme Shedding, and Lung Edema
Anesth. Analg.,
November 1, 2007;
105(5):
1363 - 1370.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Wang, T. Luo, D. Chen, and D. M. Ansley
Propofol Reduces Apoptosis and Up-Regulates Endothelial Nitric Oxide Synthase Protein Expression in Hydrogen Peroxide-Stimulated Human Umbilical Vein Endothelial Cells
Anesth. Analg.,
October 1, 2007;
105(4):
1027 - 1033.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Zhang, W. E. Lawson, V. V. Polosukhin, A. Pozzi, T. S. Blackwell, Y. Litingtung, and C. Chiang
Inhibitor of Differentiation 1 Promotes Endothelial Survival in a Bleomycin Model of Lung Injury in Mice
Am. J. Pathol.,
October 1, 2007;
171(4):
1113 - 1126.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|